Pharmacy Benefit Management Market (By Service: Specialty Pharmacy Services, Benefit Plan Design & Administration, Formulary Management, Pharmacy Claims Processing, Others; By Service Provider: Retail Pharmacies, Insurance Companies, Standalone Pharmacy Benefit Management Providers; By Business Model: Government Health Programs, Employer-sponsored Programs, Health Insurance Management) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024 – 2033
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Pharmacy Benefit Management Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Pharmacy Benefit Management Market, by Service, 2024-2033
8.1.1 Specialty Pharmacy Services
8.1.1.1. Market Revenue and Forecast (2021-2033)
8.1.2. Benefit Plan Design & Administration
8.1.2.1. Market Revenue and Forecast (2021-2033)
8.1.3. Formulary Management
8.1.3.1. Market Revenue and Forecast (2021-2033)
8.1.4. Pharmacy Claims Processing
8.1.4.1. Market Revenue and Forecast (2021-2033)
8.1.5. Others
8.1.5.1. Market Revenue and Forecast (2021-2033)
9.1. Pharmacy Benefit Management Market, by Service Provider, 2024-2033
9.1.1. Retail Pharmacies
9.1.1.1. Market Revenue and Forecast (2021-2033)
9.1.2. Insurance Companies
9.1.2.1. Market Revenue and Forecast (2021-2033)
9.1.3. Standalone Pharmacy Benefit Management Providers
9.1.3.1. Market Revenue and Forecast (2021-2033)
10.1. Pharmacy Benefit Management Market, by Business Model, 2024-2033
10.1.1. Government Health Programs
10.1.1.1. Market Revenue and Forecast (2021-2033)
10.1.2. Employer-sponsored Programs
10.1.2.1. Market Revenue and Forecast (2021-2033)
10.1.3. Health Insurance Management
10.1.3.1. Market Revenue and Forecast (2021-2033)
11.1. North America
11.1.1. Market Revenue and Forecast, by Service (2021-2033)
11.1.2. Market Revenue and Forecast, by Service Provider (2021-2033)
11.1.3. Market Revenue and Forecast, by Business Model (2021-2033)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Service (2021-2033)
11.1.4.2. Market Revenue and Forecast, by Service Provider (2021-2033)
11.1.4.3. Market Revenue and Forecast, by Business Model (2021-2033)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Service (2021-2033)
11.1.5.2. Market Revenue and Forecast, by Service Provider (2021-2033)
11.1.5.3. Market Revenue and Forecast, by Business Model (2021-2033)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Service (2021-2033)
11.2.2. Market Revenue and Forecast, by Service Provider (2021-2033)
11.2.3. Market Revenue and Forecast, by Business Model (2021-2033)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Service (2021-2033)
11.2.4.2. Market Revenue and Forecast, by Service Provider (2021-2033)
11.2.4.3. Market Revenue and Forecast, by Business Model (2021-2033)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Service (2021-2033)
11.2.5.2. Market Revenue and Forecast, by Service Provider (2021-2033)
11.2.5.3. Market Revenue and Forecast, by Business Model (2021-2033)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Service (2021-2033)
11.2.6.2. Market Revenue and Forecast, by Service Provider (2021-2033)
11.2.6.3. Market Revenue and Forecast, by Business Model (2021-2033)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Service (2021-2033)
11.2.7.2. Market Revenue and Forecast, by Service Provider (2021-2033)
11.2.7.3. Market Revenue and Forecast, by Business Model (2021-2033)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Service (2021-2033)
11.3.2. Market Revenue and Forecast, by Service Provider (2021-2033)
11.3.3. Market Revenue and Forecast, by Business Model (2021-2033)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Service (2021-2033)
11.3.4.2. Market Revenue and Forecast, by Service Provider (2021-2033)
11.3.4.3. Market Revenue and Forecast, by Business Model (2021-2033)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Service (2021-2033)
11.3.5.2. Market Revenue and Forecast, by Service Provider (2021-2033)
11.3.5.3. Market Revenue and Forecast, by Business Model (2021-2033)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Service (2021-2033)
11.3.6.2. Market Revenue and Forecast, by Service Provider (2021-2033)
11.3.6.3. Market Revenue and Forecast, by Business Model (2021-2033)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Service (2021-2033)
11.3.7.2. Market Revenue and Forecast, by Service Provider (2021-2033)
11.3.7.3. Market Revenue and Forecast, by Business Model (2021-2033)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Service (2021-2033)
11.4.2. Market Revenue and Forecast, by Service Provider (2021-2033)
11.4.3. Market Revenue and Forecast, by Business Model (2021-2033)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Service (2021-2033)
11.4.4.2. Market Revenue and Forecast, by Service Provider (2021-2033)
11.4.4.3. Market Revenue and Forecast, by Business Model (2021-2033)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Service (2021-2033)
11.4.5.2. Market Revenue and Forecast, by Service Provider (2021-2033)
11.4.5.3. Market Revenue and Forecast, by Business Model (2021-2033)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Service (2021-2033)
11.4.6.2. Market Revenue and Forecast, by Service Provider (2021-2033)
11.4.6.3. Market Revenue and Forecast, by Business Model (2021-2033)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Service (2021-2033)
11.4.7.2. Market Revenue and Forecast, by Service Provider (2021-2033)
11.4.7.3. Market Revenue and Forecast, by Business Model (2021-2033)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Service (2021-2033)
11.5.2. Market Revenue and Forecast, by Service Provider (2021-2033)
11.5.3. Market Revenue and Forecast, by Business Model (2021-2033)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Service (2021-2033)
11.5.4.2. Market Revenue and Forecast, by Service Provider (2021-2033)
11.5.4.3. Market Revenue and Forecast, by Business Model (2021-2033)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Service (2021-2033)
11.5.5.2. Market Revenue and Forecast, by Service Provider (2021-2033)
11.5.5.3. Market Revenue and Forecast, by Business Model (2021-2033)
12.1. CVS Health
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. SS&C Technologies, Inc.
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Anthem Inc.
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Medimpact
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Express Scripts Holding Company
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Benecard Services, LLC
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. CaptureRx Inc.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Change Healthcare
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. OptumRx, Inc.
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Cigna
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample